Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

ClinicalTrials.gov ID: NCT01815450

Public ClinicalTrials.gov record NCT01815450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of BLI1100 formulations to placebo for the treatment of moderate to severe acne vulgaris.

Study identification

NCT ID
NCT01815450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Braintree Laboratories
Industry
Enrollment
369 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2013 (Type not available)
Primary completion
Nov 2013 (Actual)
Completion
Not listed
Last update posted
Feb 2, 2015

Started 2013

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Center for Dermatology Clincal Research Fremont California 94538 —
North Florida Dermatology Associates Jacksonville Florida 32204 —
Ameriderm Research Ormond Beach Florida 32174 —
Peachtree Dermatology Associates Research Center Atlanta Georgia 30327 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
Clinical Partners Johnston Rhode Island 02919 —
DiscoveResearch Bryan Texas 77802 —
Suzanne Bruce and Associates Houston Texas 77056 —
Dermatology Research Center Salt Lake City Utah 84124 —
The Education and Research Foundation Lynchburg Virginia 24501 —
Women's Clinical Research Center Seattle Washington 98105 —
Premier Clinical Research Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01815450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01815450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →